Page last updated: 2024-08-22

trimetazidine and Complication, Postoperative

trimetazidine has been researched along with Complication, Postoperative in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Dai, ZL; Gao, WL; Li, Y; Lin, J; Lin, M; Song, YF; Tian, Y; Wang, P; Wang, Q1
Fang, Y; Zheng, YS; Zhu, K1
Ambesh, P; Garg, N; Goel, PK; Kapoor, A; Kashyap, S; Kazmi, DH; Khanna, R; Kumar, S; Sinha, A; Tewari, S1
Challeton, JP; Danchin, N; Ferrari, R; Ford, I; Fox, K; Marzilli, M; Tendera, M; Widimský, P1
Huang, W; Lei, H; Lei, J; Liu, Q; Xiao, H; Zhang, N1
Cui, W; Du, H; Hao, J; Li, WW; Liu, F; Lu, JC; Yang, XC; Zhao, ZF1
Assunção, CR; Bottino, F; Carvalho, KG; Martins, GF; Santos, JB; Siqueira Filho, AG; Valência, A1
Baiandin, NL; Gordeev, IG; Il'ina, EE; Kuznechevskiĭ, FV; Liusov, VA1

Reviews

1 review(s) available for trimetazidine and Complication, Postoperative

ArticleYear
The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis.
    Cardiology, 2015, Volume: 131, Issue:2

    Topics: Biomarkers; Cardiotonic Agents; Coronary Artery Bypass; Creatine Kinase, MB Form; Humans; Myocardial Reperfusion Injury; Postoperative Complications; Preoperative Care; Randomized Controlled Trials as Topic; Trimetazidine; Troponin; Vasodilator Agents

2015

Trials

4 trial(s) available for trimetazidine and Complication, Postoperative

ArticleYear
Trimetazidine offers myocardial protection in elderly coronary artery disease patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial.
    BMC cardiovascular disorders, 2021, 10-01, Volume: 21, Issue:1

    Topics: Aged; China; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Postoperative Complications; Risk Factors; Surgical Procedures, Operative; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents

2021
A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristi
    American heart journal, 2019, Volume: 210

    Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Placebos; Postoperative Complications; Recurrence; Trimetazidine; Vasodilator Agents; Young Adult

2019
Effects of atorvastatin combined with trimetazidine on myocardial injury and inflammatory mediator in unstable angina patients during perioperative of percutaneous coronary intervention.
    European review for medical and pharmacological sciences, 2015, Volume: 19, Issue:23

    Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Combined Modality Therapy; Drug Therapy, Combination; Female; Heart Injuries; Humans; Inflammation Mediators; Interferon-gamma; Male; Middle Aged; Percutaneous Coronary Intervention; Perioperative Period; Postoperative Complications; Trimetazidine; Troponin I; Tumor Necrosis Factor-alpha

2015
Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting.
    Arquivos brasileiros de cardiologia, 2011, Volume: 97, Issue:3

    Topics: Biomarkers; Coronary Artery Bypass; Creatine Kinase, MB Form; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Reperfusion Injury; Placebo Effect; Postoperative Complications; Prospective Studies; Time Factors; Treatment Outcome; Trimetazidine; Troponin T; Vasodilator Agents

2011

Other Studies

3 other study(ies) available for trimetazidine and Complication, Postoperative

ArticleYear
Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis.
    Medicine, 2020, Oct-30, Volume: 99, Issue:44

    Topics: Cardiotonic Agents; Coronary Artery Disease; Humans; Meta-Analysis as Topic; Percutaneous Coronary Intervention; Postoperative Complications; Research Design; Systematic Reviews as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents

2020
Role of metabolic manipulator trimetazidine in limiting percutaneous coronary intervention-induced myocardial injury.
    Indian heart journal, 2018, Volume: 70 Suppl 3

    Topics: Biomarkers; Coronary Angiography; Coronary Stenosis; Creatine Kinase, MB Form; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Reperfusion Injury; Percutaneous Coronary Intervention; Postoperative Complications; Prognosis; Trimetazidine; Troponin I; Vasodilator Agents

2018
[Derangements of contractility of left ventricular myocardium in patients subjected to coronary bypass surgery. Methods of their correction].
    Kardiologiia, 2007, Volume: 47, Issue:2

    Topics: Adult; Aged; Angina Pectoris; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Contraction; Postoperative Complications; Trimetazidine; Ventricular Dysfunction, Left

2007